Huwenjun

Wenjun Hu, born in 1968, PhD, Associate professor, Master's supervisor. Graduated from the Chinese Academy of Sciences, Shanghai Academy of Life Sciences with a doctor's degree in science by September 2001. Joined in the School of Life Science and Technology of China Pharmaceutical University as a teacher from October 2001 to now. Main research directions: (1) Human and mouse stem cells' development and their application; (2) Molecular identification of traditional Chinese medicinal materials.

1. Shanshan Chen, Yingjie Sun, Jianxing Liu, Wenjing Yan，Jiakun Liu，Wenjun Hu. The Progress of Common Treatments and Research for Androgenetic Alopecia[J]，Current Research in Medical Sciences，2023,2（2）：46-51

2. Xiaoyan Zhang, Yugui Cui, Lianju Qin, Wenjun Hu; Progress in Differentiation of Human Pluripotent Stem Cells into Epithelial Cells, [J], Chinese Journal of Pharmaceutical Biotechnology, 2023,30(02):200-206.

3. LI Cheng, CUI Yu-gui, QIN Lian-ju, HU Wen-jun. The Effect and Mechanism of Epimedium (Icariin) on Male Reproductive System[J]. Journal of International Reproductive Health/Family Planning, 2022, 41(3): 236-239.

4、Xiansheng Zhao, Jiamin Guo, Fangfang Zhang, Jue Zhang, Delin Liu, Wenjun Hu*, Han Yin* and Liang Jin，Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot，Stem Cell Research & Therapy (2020) 11:394-401.

1.Basic research expenses for universities, the role and mechanism of icariin in promoting sperm development, 2021-2022, Hosted and completed.

2. National Natural Science Foundation of China, Research on the Application of DNA Barcode Technology in the Identification and Quality Control of Tibetan Medicine Honglian, 2019-2022, Hosted and completed.